How to buy Ortho Clinical Diagnostics Holdings plc stock (Ortho Clinical Diagnostics Holdings plc)

Ortho Clinical Diagnostics Holdings plc is a health care equipment & supplies business based in the US. Ortho Clinical Diagnostics Holdings plc shares (OCDX) are listed on the NASDAQ and all prices are listed in US Dollars. Ortho Clinical Diagnostics Holdings plc employs 4,800 staff and has a trailing 12-month revenue of around $2 billion.

Our top picks for where to buy Ortho Clinical Diagnostics stock

Buy Ortho Clinical Diagnostics Holdings plc stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Ortho Clinical Diagnostics Holdings plc stock price (NASDAQ: OCDX)

Use our graph to track the performance of OCDX stocks over time.

Ortho Clinical Diagnostics Holdings plc shares at a glance

• Key figures

Information last updated 2022-11-06.

52-week range	$0.00 - $0.00
50-day moving average more info button	$18.12
200-day moving average more info button	$18.77
Wall St. target price	$20.96
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$0.00

Is it a good time to buy Ortho Clinical Diagnostics Holdings plc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Ortho Clinical Diagnostics Holdings plc stock undervalued or overvalued?

Valuing Ortho Clinical Diagnostics Holdings plc stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ortho Clinical Diagnostics Holdings plc's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Ortho Clinical Diagnostics Holdings plc's EBITDA

Ortho Clinical Diagnostics Holdings plc's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $450.5 million.

The EBITDA is a measure of a Ortho Clinical Diagnostics Holdings plc's overall financial performance and is widely used to measure a its profitability.

To put Ortho Clinical Diagnostics Holdings plc's EBITDA into context you can compare it against that of similar companies.

• Trinity Biotech (TRIB.US): USD$-11297000
• Meridian Bioscience (VIVO.US): USD$92.1 million
• IDEXX Laboratories (IDXX.US): USD$1.3 billion

Ortho Clinical Diagnostics Holdings plc financials

Revenue TTM	$2 billion
Operating margin TTM	8.48%
Gross profit TTM	$1 billion
Return on assets TTM	3.22%
Return on equity TTM	-0.1%
Profit margin	-0.02%
Book value	$1.87
Market Capitalization more info button	$4.2 billion

TTM: trailing 12 months

Ortho Clinical Diagnostics Holdings plc share dividends

We're not expecting Ortho Clinical Diagnostics Holdings plc to pay a dividend over the next 12 months.

You may also wish to consider:

Ortho Clinical Diagnostics Holdings plc overview

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey. As of May 27, 2022, Ortho Clinical Diagnostics Holdings plc operates as a subsidiary of Quidel Corporation.

Frequently asked questions

What percentage of Ortho Clinical Diagnostics Holdings plc is owned by insiders or institutions?
Currently 0.383% of Ortho Clinical Diagnostics Holdings plc shares are held by insiders and 98.306% by institutions. How many people work for Ortho Clinical Diagnostics Holdings plc?
Latest data suggests 4,800 work at Ortho Clinical Diagnostics Holdings plc. When does the fiscal year end for Ortho Clinical Diagnostics Holdings plc?
Ortho Clinical Diagnostics Holdings plc's fiscal year ends in December. Where is Ortho Clinical Diagnostics Holdings plc based?
Ortho Clinical Diagnostics Holdings plc's address is: 1001 Route 202, Raritan, NJ, United States, 08869 What is Ortho Clinical Diagnostics Holdings plc's ISIN number?
Ortho Clinical Diagnostics Holdings plc's international securities identification number is: GB00BMDNH979